Regulatory Affairs and Pharmacoeconomic (RAPhe)

Our expert team in regulatory and pharmacoeconomics can help you at any stage of the treatment intervention lifecycle. From assessing what type of intervention it may be – drug, medical device or otherwise – to determining translational and regulatory strategy, managing the entire regulatory side of projects and determining critical and other product and project parameters, to the final stage of pricing settings. Our team is made up of seasoned experts with long experience and we continuously monitor global trends, publish our research results and seek new solutions to pressing issues. Just as regulatory expertise is fundamental to the successful development of any product in the medical field, pharmacoeconomics and health technology assessment is a key element for decision-making processes, including cost-effectiveness, cost-utility, value proposition and therapeutic impact data. All of these determine the affordability of treatment for the patient.